Healthcare & Life Sciences
medarex
United States
pre-ipo
pre-ipo
Stage
About
Medarex was a biopharmaceutical company specializing in the discovery, development, and commercialization of therapeutic antibodies for cancer and autoimmune disorders.
Explore medarex's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.